Bennett Kirsty F, Waller Jo, Chorley Amanda J, Ferrer Rebecca A, Haddrell Jessica B, Marlow Laura Av
1 Cancer Communication and Screening Group, Department of Behavioural Science and Health, UCL, London, UK.
2 Basic Biobehavioral and Psychological Sciences Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, USA.
J Med Screen. 2018 Dec;25(4):211-217. doi: 10.1177/0969141318767471. Epub 2018 Apr 13.
Understanding why some women actively decline cervical screening could contribute to tailored intervention development. We explored reasons for non-participation in cervical screening among women who had made an active decision not to attend in the future. We also explored interest in human papillomavirus self-sampling.
In a population-based survey of women in Great Britain, home-based computer-assisted interviews were carried out with screening eligible women. Women reported their intention to attend for screening when next invited. They endorsed predefined barriers to screening and indicated their interest in human papillomavirus self-sampling.
Women who had actively declined screening and those who intended to go but were currently overdue (n=543) were included in this analysis. Women who had made an active decision not to be screened in the future were more likely to endorse the barriers 'I have other more important things to worry about' and to perceive screening to be of low relevance based on their sexual behaviour. Most participants (70%) indicated that they would be interested in human papillomavirus self-sampling. Interest in self-sampling was greater among those who reported having had a bad experience of screening in the past, were too busy or embarrassed to attend, or would not want a man to carry out the test.
Women who had made an active decision not to attend screening felt it was of low relevance to them and that they had more important things to worry about. Shifting the perceived cost-benefit ratio for these women by offering human papillomavirus self-sampling might increase screening participation in this group.
了解为何有些女性主动拒绝宫颈筛查,这有助于制定针对性的干预措施。我们探究了那些已主动决定未来不再参加宫颈筛查的女性不参与筛查的原因。我们还探究了她们对人乳头瘤病毒自我采样的兴趣。
在一项针对英国女性的基于人群的调查中,对符合筛查条件的女性进行了上门电脑辅助访谈。女性报告了她们下次收到邀请时参加筛查的意愿。她们认可了预先定义的筛查障碍,并表明了对人乳头瘤病毒自我采样的兴趣。
主动拒绝筛查的女性以及打算参加但目前已逾期未筛查的女性(n = 543)被纳入本分析。那些已主动决定未来不再接受筛查的女性更有可能认可“我有其他更重要的事情要担心”这一障碍,并基于其性行为认为筛查相关性较低。大多数参与者(70%)表示她们会对人乳头瘤病毒自我采样感兴趣。过去有过糟糕筛查经历、太忙或不好意思参加筛查,或者不希望男性进行检测的女性对自我采样的兴趣更大。
那些已主动决定不参加筛查的女性认为筛查与她们相关性较低,且她们有更重要的事情要担心。通过提供人乳头瘤病毒自我采样来改变这些女性所感知的成本效益比,可能会提高该群体的筛查参与率。